IKNA

Ikena Oncology, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website ikenaoncology.com
Employees(FY) 57
ISIN US45175G1085

Performance

-6.63%

-7.74%

-9.36%

-8.82%

-21.32%

YTD

-20.51%

Profile

Ikena Oncology, Inc. operates as an oncology company that develops precision medicines to biomarker-defined patients with specific unmet needs in the United States. Its lead oncology product candidate is IK-930, a paralog selective inhibitor of the transcriptional enhanced associate domain, a transcription factor in the Hippo signaling pathway. It also develops IK-595, designed to trap MEK and RAF for inhibiting RAS signals than existing inhibitors; and IK-175, a monotherapy and in combination with nivolumab in patients with advanced or metastatic solid tumors, including urothelial carcinomas. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Advanced Technical Analysis

Technical Analysis of IKNA 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 3 and the Technical Score at 21, both indicating weak performance. The Oscillators Score of 40 suggests a neutral stance, but overall, the combined scores point to a lack of bullish momentum in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of IKNA

Stock Rank

Recent News & Updates

2024-11-06 19:30
Ikena Oncology Reports Third Quarter 2024 Financial Results(Globenewswire)
2024-08-08 04:15
Ikena Oncology Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-05-28 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-28 04:42
UPDATE Ikena Oncology Announces Strategic Update(Globenewswire)
2024-05-28 04:15
Ikena Oncology Announces Strategic Update(Globenewswire)
2024-05-13 08:52
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024(Investorplace)
2024-05-13 04:45
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update(Globenewswire)
2024-04-09 20:00
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum(Globenewswire)
2024-03-11 20:00
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-02-26 19:00
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference(Globenewswire)
2024-02-21 03:15
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer(Globenewswire)
2024-02-13 20:35
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround(Zacks)
2024-01-23 20:35
Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround(Zacks)
2024-01-18 17:25
Ikena Oncology to lay off 35% of staff(Yahoo Finance)
2024-01-18 03:05
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates(Globenewswire)
2023-11-08 18:00
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results(Globenewswire)
2023-11-06 19:00
Ikena Oncology to Present at Multiple November 2023 Investor Conferences(Globenewswire)
2023-09-26 21:01
Pliant Therapeutics, Inc. (PLRX) Soars 14.3%: Is Further Upside Left in the Stock?(Yahoo Finance)
2023-09-04 20:00
Ikena Oncology to Participate in September 2023 Investor Conferences(Yahoo Finance)
2023-08-11 20:07
Downgrade: Here's How Analysts See Ikena Oncology, Inc. (NASDAQ:IKNA) Performing In The Near Term(Yahoo Finance)
2023-08-09 21:30
Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Lags Revenue Estimates(Yahoo Finance)
2023-08-09 20:00
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update(Yahoo Finance)
2023-08-09 18:08
The Petri Dish: Agios licenses Alnylam drug, Ikena acquires startup with Gilead stake(Yahoo Finance)
2023-08-07 20:24
Loss-making Ikena Oncology (NASDAQ:IKNA) sheds a further US$11m, taking total shareholder losses to 22% over 1 year(Yahoo Finance)
2023-08-06 19:00
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction(Yahoo Finance)
2023-06-19 20:50
Recent Price Trend in Ikena Oncology, Inc. (IKNA) is Your Friend, Here's Why(Yahoo Finance)
2023-06-05 02:59
We're Keeping An Eye On Ikena Oncology's (NASDAQ:IKNA) Cash Burn Rate(Yahoo Finance)
2023-06-01 20:50
Ikena Oncology, Inc. (IKNA) Is a Great Choice for 'Trend' Investors, Here's Why(Yahoo Finance)
2023-05-23 20:00
Ikena Oncology to Participate in Upcoming Investor Conferences(Yahoo Finance)
2023-05-15 20:29
Party Time: Brokers Just Made Major Increases To Their Ikena Oncology, Inc. (NASDAQ:IKNA) Earnings Forecasts(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.